Oorja Bio
4 known investors
Find your way into Oorja Bio
335 people in our graph share verified history with the Oorja Bio team — schools, employers, funds. One of them is your warm intro.
Kelli McKeirnanunlockedknows Connie Coulomb · together at Amgen (overlapped)
×8knows the team · via Amgen
×3knows the team · via University of Buenos Aires
Oorja Bio is a biotechnology company developing therapies focused on fibrotic disease, aiming to repair, reverse, and remodel fibrosis.
Founders & leadership
SK
Sujay KangoinChief Executive Officer & Founder
JP
Janethe PenainChief Medical Officer & Founder
CC
Connie CoulombinChief Business Officer & FounderConnie Coulomb is Chief Business Officer and Co-Founder of Oorja Bio, a biotechnology company developing therapies for fibrotic disease. She brings over 25 years of biotech and pharmaceutical executive experience, including prior roles leading commercial and strategic operations at Merck, Amgen, Biogen, and Onyx Pharmaceuticals.
Investors · 4
Funding
SEC filings, press & company announcements$30M disclosed across 1 of 3 rounds · 2026
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Oorja Bio do?
- Oorja Bio is a biotechnology company developing therapies focused on fibrotic disease, aiming to repair, reverse, and remodel fibrosis.
- Who founded Oorja Bio?
- Oorja Bio was founded by Sujay Kango, Janethe Pena, Connie Coulomb.
- Who are Oorja Bio's investors?
- Oorja Bio's investors include Andreessen Horowitz, Westlake Village BioPartners, Kleiner Perkins, Westlake BioPartners.
- How much funding has Oorja Bio raised?
- Oorja Bio has disclosed $30M raised across 1 of its 3 known rounds.